Bioteknika Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 13-12-2024
- Paid Up Capital ₹ 1.00 M
as on 13-12-2024
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.00 Cr
as on 13-12-2024
- Revenue -66.33%
(FY 2021)
- Profit 54.38%
(FY 2021)
- Ebitda 162.25%
(FY 2021)
- Net Worth -28.70%
(FY 2021)
- Total Assets -23.09%
(FY 2021)
About Bioteknika Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹1.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Pankaj Dhole and Kuber Pandya serve as directors at the Company.
- CIN/LLPIN
U33111GJ2014PTC080084
- Company No.
080084
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Bioteknika Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Dhole  | Director | 10-Jul-2014 | Current |
| Kuber Pandya | Director | 10-Jul-2014 | Current |
Financial Performance of Bioteknika Technologies.
Bioteknika Technologies Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 66.33% decrease. The company also saw a substantial improvement in profitability, with a 54.38% increase in profit. The company's net worth observed a substantial decline by a decrease of 28.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioteknika Technologies?
In 2020, Bioteknika Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bioteknika Healthcare Private LimitedActive 13 years 9 monthsPankaj Dhole and Kuber Pandya are mutual person
Bioteknika Medical Solutions Private LimitedActive 2 years 11 monthsPankaj Dhole and Kuber Pandya are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 26 Aug 2014 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Bioteknika Technologies?
Bioteknika Technologies has a workforce of 14 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioteknika Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioteknika Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
